CWM
BIIB icon

CarsonAllaria Wealth Management’s Biogen BIIB Stock Holding History

CarsonAllaria Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15
Closed -$2.05K – 361
2025
Q1 		$2.05K Hold
15
– – ﹤0.01% 323
2024
Q4 		$2.29K Hold
15
– – ﹤0.01% 307
2024
Q3 		$2.91K Buy
+15
New +$3.14K ﹤0.01% 329

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CarsonAllaria Wealth Management's BIIB Position: Q2 2025 in Review

CarsonAllaria Wealth Management sold out of Biogen (BIIB) in Q2 2025, closing a stake of 15 shares — an estimated $2.05K sold.

CarsonAllaria Wealth Management first reported a position in BIIB in Q3 2024 and held it in 3 quarters. The position peaked at $2.91K in Q3 2024. 866 funds tracked by Wall St. Rank hold BIIB as of Q2 2025.

  • CarsonAllaria Wealth Management reported no remaining Biogen position as of Q2 2025 after selling out during the quarter.
  • CarsonAllaria Wealth Management sold 15 Biogen shares in Q2 2025, an estimated $2.05K.
  • CarsonAllaria Wealth Management first reported a position in Biogen in Q3 2024 and held it in 3 quarters.
  • CarsonAllaria Wealth Management's Biogen position peaked at $2.91K in Q3 2024.
  • 866 funds tracked by Wall St. Rank held Biogen as of Q2 2025.

Based on CarsonAllaria Wealth Management's 13F filing for Q2 2025, filed 24 Jul 2025.